Mathias Hukkelhoven insider trades

Open-market stock purchases and sales by Mathias Hukkelhoven, Director at Centessa Pharmaceuticals plc, from SEC Form 4 filings since Jul 1, 2022.

Recent trades

DateStockTradeValue
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$496K
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$497K
Jun 24, 2026CNTA Centessa Pharmaceuticals plcSold (not open market)$427K

Companies traded

  • CNTA Centessa Pharmaceuticals plc: other filings, last Jun 24, 2026

Get free alerts when Mathias Hukkelhoven files a new trade →